A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Clinical Outcomes, Antiviral Activity, Safety, Tolerability, Pharmacokinetics, and Pharmacokinetics/Pharmacodynamics of JNJ-53718678 in Adult and Adolescent Hematopoietic Stem Cell Transplant Recipients with Respiratory Syncytial Virus Infection of the Upper Respiratory Tract (FREESIA)

  • Curtis, David (Primary Chief Investigator (PCI))
  • Kliman, David (Primary Chief Investigator (PCI))
  • Kennedy, Nola (Project Manager)
  • Thompson, Katherine (Project Manager)

Project: Research

Project Details

Effective start/end date15/01/2031/12/25


  • Clinical Haematology
  • Respiratory medicine
  • Clinical trial